GDRX
Goodrx Holdings Inc
NASDAQ: GDRX · HEALTHCARE · HEALTH INFORMATION SERVICES
$2.36
+3.06% today
Updated 2026-04-30
Market cap
$781.07M
P/E ratio
25.33
P/S ratio
0.98x
EPS (TTM)
$0.09
Dividend yield
—
52W range
$2 – $6
Volume
2.4M
Goodrx Holdings Inc (GDRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $45.25M | $83.29M | $131.34M | $178.78M | $146.78M | $138.29M | $183.89M | $167.90M |
| Capital expenditures | $3.46M | $5.75M | $35.82M | $34.46M | $55.21M | $55.77M | $70.35M | $3.52M |
| Depreciation | $9.81M | $13.57M | $18.43M | $34.54M | $54.18M | $111.77M | $69.54M | — |
| Stock-based comp | $1.76M | $3.75M | $397.29M | $160.46M | $120.23M | $104.82M | $99.03M | $58.66M |
| Free cash flow | $41.80M | $77.54M | $95.52M | $144.32M | $91.57M | $82.53M | $113.55M | $164.38M |
| Investing cash flow | $-3.46M | $-37.05M | $-91.62M | $-178.73M | $-210.50M | $-55.77M | $-70.35M | — |
| Financing cash flow | $-24.73M | $-54.78M | $905.82M | $-30.53M | $-120.23M | $-167.40M | $-337.50M | — |
| Dividends paid | $1.35B | $0.00 | $78.71M | $22.67M | — | $1.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $945.54M | $-30.48M | $-183.94M | — | — | — |